We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

125 hedge funds and large institutions have $1.4B invested in Ventyx Biosciences in 2022 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 53 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,551% more call options, than puts

Call options by funds: $1.62M | Put options by funds: $98K

141% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 22

131% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 16

20% more funds holding

Funds holding: 104 → 125 (+21)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

1% less capital invested

Capital invested by funds: $1.41B → $1.4B (-$12.9M)

4.47% less ownership

Funds ownership: 79.74% → 75.27% (-4.5%)

Holders
125
Holders Change
+21
Holders Change %
+20.19%
% of All Funds
2.01%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
37
Increased
53
Reduced
22
Closed
16
Calls
$1.62M
Puts
$98K
Net Calls
+$1.52M
Net Calls Change
+$1.8M

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$62.6M
2
APM
Avidity Partners Management
Texas
+$38.1M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$33.2M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$30.2M
5
TCM
TCG Crossover Management
California
+$23.3M

Top Sellers

Rank Fund Capital Flow
1
TP
Third Point
New York
-$98.1M
2
DGM
Darwin Global Management
Jersey
-$48.9M
3
VP
venBio Partners
California
-$45.9M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$34.5M
5
LGM
Logos Global Management
California
-$21.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
51
Russell Investments Group
United Kingdom
$2.38M +$2.15M +72,533 New
SCM
52
Soleus Capital Management
Connecticut
$2.26M +$2.04M +69,000 New
EI
53
EAM Investors
California
$2.13M -$542K -18,311 -22%
Squarepoint
54
Squarepoint
New York
$2.03M +$1.84M +61,967 New
Bank of America
55
Bank of America
North Carolina
$1.76M +$1.27M +42,965 +399%
Goldman Sachs
56
Goldman Sachs
New York
$1.52M +$654K +22,086 +91%
EGI
57
EAM Global Investors
California
$1.51M -$771K -26,028 -36%
Manulife (Manufacturers Life Insurance)
58
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.35M +$389K +13,120 +47%
Swiss National Bank
59
Swiss National Bank
Switzerland
$1.34M +$1.21M +40,900 New
AA
60
ALPS Advisors
Colorado
$1.26M +$1.14M +38,391 New
JF
61
Jump Financial
Illinois
$1.15M +$1.04M +35,070 New
AR
62
Advisory Research
Illinois
$1.1M +$55.5K +1,874 +6%
HS
63
HighVista Strategies
Massachusetts
$1.09M +$985K +33,256 New
TD Asset Management
64
TD Asset Management
Ontario, Canada
$1.01M +$432K +14,596 +90%
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$997K +$73K +2,464 +9%
Two Sigma Advisers
66
Two Sigma Advisers
New York
$984K +$652K +22,000 +275%
FAM
67
Fred Alger Management
New York
$928K +$486K +16,411 +138%
AllianceBernstein
68
AllianceBernstein
Tennessee
$872K +$338K +11,400 +75%
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$809K +$469K +15,832 +179%
BC
70
Birchview Capital
Vermont
$721K -$681K -23,000 -51%
CCMU
71
Cheyne Capital Management (UK)
United Kingdom
$657K +$593K +20,035 New
CC
72
Callan Capital
California
$629K +$568K +19,180 New
State of Wisconsin Investment Board
73
State of Wisconsin Investment Board
Wisconsin
$558K +$504K +17,015 New
JP Morgan Chase
74
JP Morgan Chase
New York
$556K +$139K +4,705 +38%
SEI Investments
75
SEI Investments
Pennsylvania
$527K +$132K +4,452 +38%
1 2
3
4 5

VTYX Hedge Fund Activity: Q4 2022 in Review

125 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q4 2022, worth a combined $1.4B — down 0.91% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new VTYX positions and 16 closed out — a net gain of 21 holders — while 53 added to existing stakes and 22 trimmed.

The largest buyer was Capital International Investors, opening a new position worth an estimated $62.6M. The largest seller was Third Point, cutting an estimated $98.1M.

  • 125 institutional investors held Ventyx Biosciences (VTYX) as of Q4 2022, up from 104 in Q3 2022.
  • Funds reported $1.4B of Ventyx Biosciences stock for Q4 2022, down 0.91% quarter-over-quarter.
  • 37 funds opened new Ventyx Biosciences positions in Q4 2022 and 16 closed out, a net change of +21 holders.
  • The largest Ventyx Biosciences buyer in Q4 2022 was Capital International Investors, an estimated $62.6M added.
  • The largest Ventyx Biosciences seller in Q4 2022 was Third Point, an estimated $98.1M sold.

Based on aggregated 13F filings for Q4 2022.